DAFTAR PUSTAKA Adrogue,H.J., Madias, N.E., 2007. Mechanisms of Disease Sodium and Potassium PERBANDINGAN ANGKA KEJADIAN HIPERTROFI VENTRIKEL KIRI BERDASARKAN ELEKTROKARDIOGRAFI ANTARA PRIA DAN WANITA PADA PENDERITA HIPERTENSI DI RSUD DR. MOEWARDI SURA
DAFTAR PUSTAKA
Adrogue,H.J., Madias, N.E., 2007. Mechanisms of Disease Sodium and Potassium
in the Pathogenesis of Hypertension. The New England Journal of
Medicine. 356:19.
Almaguer., Desai, M.Y., Mannting, F., 2009. Detection of Left Ventricular
Hypertrophy
by
Tc-99
TetrofosminGated-SPECT.
Medicina
Universitaria. 11(42):29-35.
Anggraini, A.D., Waren, A., Situmorang E., et al., 2009. Faktor –Faktor yang
berhubungan dengan Kejadian Hipertensi pada Pasien yang Berobat di
Poliklinik Dewasa Puskesmas Bangkinang Periode Januari Sampai Juni
2008. Riau : FK UNRI. h:1-7.
Ballistrieri, T., Mussato, K., 2008. dalam Pathophysiology Concepts of Altered
Health States (8th ed.). Philadelphia: Lippincott Williams & Wilkins. pp:
512-21.
Bandiara, R., 2008. An Update Management Concept in Hypertension.
SubBagian Ginjal Hipertensi Bag. Ilmu Penyakit Dalam FK UNPAD/RS
Dr.Hasan Sadikin. Bandung.
Barrios, V., Escobar, C., Calderon, A., et al., 2009. Electrocardiography Left
Ventricular Hypertrophy Regression Induced by an Angiotensin Receptor
Blocker-Based Regimen in Hypertensive Patients with Diabetes: Data
From The SARA Study. Journal of Renin-Angiotesin-Aldosterone System.
10: 168.
Borah, P.K., Hazarika, N.C., Biswas, D., Kalita, H.C., Mahanta, J., 2010.
Population-Specific Left Ventricular Hypertrophy in Three Groups from
The Northeastern Region of India. The National Medical Journal of
Indian. 23(6) :336-9.
Brashers, V.L., McCance, K.L., 2010. Structure and Function of The
Cardiovascular and Lymphatic Systems dalam Pathophysiology The
Biologic Basis For Disease in Adult and Children (6th ed.). Philadelphia:
Elsevier. pp: 1149-52.
Brilla, C.G., 2000. Clinical Relevance of Left Ventricular Hypertrophy Regression
dalam Heart and Metabolisme.Division of Cardiology, Philipps
University, Marburg, Germany. p: 14-9.
Brown, D.M., Giles, W.H., Croft, J.B., 2000. Left Ventricular Hypertrophy As A
Predictor of Coronary Heart Disease Mortality and The Effect of
Hypertension. American Heart J Vol140 No.6. pp: 848-56.
Dahlan, S., 2004. Uji Hipotesis Komparatif Variabel Numerik 2 Kelompok dlam
Seri Statistik: Statistik untuk Kedokteran dan Kesehatan Uji Hipotesis
dengan Menggunakan SPSS Program 12 Jam. Jakarta: Arkans. h:77-8.
Departemen Kesehatan RI. 2007. Pedoman Pengendalian Penyakit Jantung dan
Pembuluh Darah. Jakarta. h:11.
Dominiczak, A.F.,Munroe, B.P., 2010. Genome-Wide Association Studies Will
Unlock the Genetic Basis of Hypertension. Hypertension The Journal of
American Heart Association. 56:1017-20.
Dorland, W. A. N, 2002. Dorlan’s Illustrated Medical Dictionary (29th ed.).
Hartanto, H et al. (Alih Bahasa). Jakarta: EGC.
Douglas, P.S., Kaplan, N.M., 2010. Definition and Pathogenesis of Left
Ventricular Hypertrophy in Hypertension. In G.L. Bakris; A.M. Sheridan;
G.M. Saperia (Eds) Up To Date 18.3, Up To Date, Waltham, MA.
Dubey, R.K., Oparil, S., Imthurn, B., Jackson, E.K., 2002. Sex Hormones and
Hypertension. Cardiovascular Research. 53:688-708.
Efendi, D. 2003. Korelasi Dispersi QT dengan Hipertrofi Ventrikel Kiri pada
Penderita Hipertensi. Bagian Ilmu Penyakit Dalam Fakultas Kedokteran
Universitas Sumatera Utara. Sumatera Utara. h:1-6.
Elliott, W.J., Bakris., Black., 2004. Systemic Arterial Hypertension dalam Hurst’s
The Heart (11th ed.). New York: McGraw Hill Companies. pp: 1534-38.
Federal Bureau of Prisons. 2004. Hypertension dalam Clinical Practice
Guidelines. pp:1. Diakses pada 28 November 2010 dari
http://www.pdfchaser.com/pdf/Federal-Bureau-of-Prisons-Clinical
Guidelines-for-Social-Work-....html.
Gray, H.H., Dawskins, K.D., Simpson, L.A., Morgan, J.M., 2002. Hipertensi
dalam Lecture Notes on Cardiology (4th ed.). Agus, A., Rachmawati,
A.D. (Alih Bahasa). Jakarta: Erlangga. h: 58.
Gregg, E.W., Gu, Q., Cheng, Y.J., et al., 2007. Mortality Trends in Men and
Women with Diabetes, 1971 to 2000. Annals of Internal Medicine.
147:149-55.
Guyton, A.C., Hall, J.E., 2006. dalam Textbook Of Medical Physiology (11th ed.).
Irawati. et al. (Alih Bahasa). Jakarta: EGC. h: 172.
Idham, I., Sanjaya, W., 2005. Angiotensin-II dan Remodelling Vaskuler dalam
Cermin Dunia Kedokteran No. 147. Departemen Kardiologi dan
Kedokteran Vaskuler Fakultas Kedokteran Universitas Indonesia/ Rumah
Sakit Jantung dan Pembuluh Darah Harapan Kita. h: 16-9.
Hampton, J.R., 2006. dalam Dasar-Dasar EKG (ed. 6). Jakarta: EGC. h:24.
Hinderliter, A.L., Colindres, R.E., 2004. Hypertension dalam international
Student Edition Netter’s Cardiology (1st ed.). USA: Icon Learning
System. pp: 377.
Izzo, J.L., Gradman, A.H., 2004. Mechanisms and Management of Hypertensive
Heart Disease: From Left Ventricular Hypertrophy to Heart Failure. The
Medical Clinics of North America. USA. 88:1257-71.
Julian, D.G., Cowan, J.C., McLenachan, J.M., 2005. Hypertension and Heart
Disease
dalam
Cardiology
(8thed.).
Philadelphia:
Elsevier
Sauders.pp:304-305.
Kaplan, N.M. 2001. Hypertension and Atherosclerotic Vascular Disease dalam
Heart Disease (6th ed.). Philadelphia: W.B. Saunders Company. pp:94157.
Khalil, R.A., 2005. Sex Hormones as Potential Modulators of Vascular Function
in Hypertension. Hypertension The Journal of American Heart
Association. 46:249-254.
Khalil, S.A., Zaimi, S., Tazi, M.A., et al.,2009. Prevalence and Predictors of
White-Coat Hypertension in A Large Database of Ambulatory Blood
Pressure Monitoring. La Revue de Santé de la Méditerranée orientale
Vol. 15. pp:401.
Kotchen, T.A. 2008. Hypertension Vascular Disease dalam Harrison’s Principles
of Internal Medicine (17th ed.). New York: McGraw Hill Companies. pp:
1549-52.
Lip, G.Y.H., Felmeden, D.C., Beevers, D.G., 2000. Hypertension Heart Disease A
Complex Syndrome or A Hypertensive Cardiomyopathy? European
Heart Journal. 21:1653-65.
Luchner, A., Brockel, U., Muscholl, M., et al., 2002. Gender-Specific Differences
of Cardiac Remodeling in Subjects with Left Ventricular Dysfunction: A
Population-Based Study. Cardiovascular Research. 53:720–27.
Morrison, I.,, Clark, E., Macfarlane, P.W., 2007. Evaluation of The
Electrocardiographic Criteria for Left Ventricular Hypertrophy. Anatol J
Cardiol. 7:159-63.
Murti, B., 2006. Desain dan ukuran sampel untuk penelitian kuantitatif dan
Kualitatif di Bidang Kesehatan. Yogyakarta: Gajah Mada University
Press. h:112.
Nadar, S., Lip, G.Y.H., 2010. Hypertension and Target Organ Damage: Focus on
Left Ventricular Hypertrophy. The Year in Hypertension. Atlas Medical
Publishing Ltd. 32-44.
National High Blood Pressure Education Program Coordinating Commitee, 2003.
The seventh report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure.
Hypertension The Journal of American Heart Association. 42:1206-52.
Notoadmodjo, S., 2002. Metodologi Penelitian Kesehatan. Rineka Cipta. Jakarta.
h:88.
Panggabean, M.M. 2007. Penyakit Jantung Hipertensi dalam Buku Ajar Ilmu
Penyakit Dalam Jilid III (ed.4). Jakarta: Fakultas Kedokteran UI. h: 1639.
Pepine, C.J., Nicolas, W.W., Pauly, D.F., 2006. Estrogen and Different Aspects
of Vascular Disease in Women and Men dalam Circulation Research of
American Heart Association. American Heart Association. Greenville
Avenue, Dallas. pp: 459-60.
Purwanto, B., 2010. Current Rational Management of Hypertension Based on Its
Pathophysiology dalam MakalahOne Day Symposium Update
Management of Hypertension and Its Complication. pp: 20.
Roseim E.A., Muiesan, M.L., 2005. Pathophysiology and Treatment of
Hypertensive Left Ventricular Hypertrophy. Hypertension&Left
Ventricular Hypertrophy. Dialogues in Cardiovascular Medicine. 10: 318.
Rosei, E.A., Muiesan, M.L., Salvetti, M., 2006. Evaluation of Subclinical Target
Organ Damage for Risk Assessment and Treatment in the Hypertensive
Patients: Left Ventricular Hypertrophy. Journal American Society of
Nephrology. 17:104-8.
Radin, M.J., Holycross, B.J., Sharkey, L.C., et al., 2001. Gender Modulates
Activation of Renin-Angiotensin and Endothelin Systems in Hypertension
and Heart Failure. J Appl Physiol. 92:935-940.
Reckelhoff, J.F., 2005. Sex Steroid, Cardiovascular Disease, and Hypertension:
Unanswered Question and Some Speculations. Hypertension The Journal
of American Heart Association. 45:170-74.
Saitoh, M., Nishimura, H., Tanaka, T., Kondoh, T., 2005. Gender Related
Differences in Target Organ Damage in Untreated Patients with
Essential Hypertension. Internal Medicine.45.1503: 377-83.
Samarel, A.M., Walsh, R.A., 2008. Molecular and Cellular Biology of the
Normal, Hypertrophied, and Failibg Heart dalam Hurst’s The Heart
(12th ed.). New York: McGraw Hill. pp: 123-25.
Sanjaya, W., Soerinata, S., 2004. Peranan Faktor-Faktor Hemodinamik dan Non
Hemodinamik Dalam Mekanisme Patogenik Hipertrofi Ventrikel Kiri
dalam Cermin Dunia Kedokteran No. 143. Departemen Kardiologi dan
Kedokteran Vaskuler Fakultas Kedokteran Universitas Indonesia/ Rumah
Sakit Pusat Jantung Nasional Harapan Kita. Jakarta. h:15.
Sastroasmoro, S., 2008. Dasar – Dasar Metodologi Penelitian Klinis. Jakarta:
Sagung Seto. h:293.
Schreiber, M.J., Vidt, J.D.G., 2005. Hallmarks of Essential and Secondary
Hypertension dalam The Cleveland Clinic Intensive Review of Internal
Medicine (4th ed.). Philadelphia: Lippincott Williams & Wilkins.pp: 60210.
Sherwood, L., 2001. Human Physiology : From Cells to System Cetakan I.
Jakarta: EGC. pp: 300.
Soerinata, S., Sanjaya, W., 2005. Peranan Penghambat Reseptor Angiotensin II
dalam Hipertrofi Ventrikel Kiri dalam Cermin Dunia Kedokteran No.
147. Departemen Kardiologi dan Kedokteran Vaskuler Fakultas
Kedokteran Universitas Indonesia/ Rumah Sakit Jantung dan Pembuluh
Darah Harapan Kita. h: 13-5.
Spencer, C.G.C., Lip, G.Y.H., 2000. Target Organ Damage in Hypertension:
Who is at Risk? University Departement of Medicine, City Hospital,
Birmingham, UK. p:9-13.
Sugiyono. 2006. Statistika untuk Penelitian. Bandung: Alfabeta.
Talwar, S., Siebenhofer, A., Williams, B., Ng, L., 2000. Influence of
Hypertension, Left Ventricular Systolic Dysfunction on Plasma N
terminal proBNP. Heart. 83:278-82.
Tessy, A. 2007. Hipertensi pada Penyakit Ginjal dalam Buku Ajar Ilmu Penyakit
Dalam Jilid I (ed. 4). Jakarta: Fakultas Kedokteran UI. h: 604.
Victor, R. 2003. Arterial Hypertension dalam Cecil Textbook of Medicine (22nd
ed.). Philadelphia: Saunders. pp:347.
Vikrant, S., Tiwari, S.C., 2001. Essential Hypertension Pathogenesis and
Pathophysiology dalam Indian Academy of Clinical Medicine Vol.2 JulySeptember No.3. pp:140-57.
Wasterhout,C.M., Lauer, M.S., James, S., et al., 2007. Electrocardiographic Left
Ventricular Hypertrophy in GUSTO IV ACS: An Important Risk Marker
of Mortality in Women. European Heart Journal. 28: 2064–69.
Wiss, A.J.W. 2005. dalam Pathophysiology An Essential Text For The Allied
Health Professions. Philadelphia: Elsevier. pp:342-44.
Xin, Y., Song, X., Xue, H., et al., 2009. A Common Variant of The eNOS
geneb(E298D) is an Independent Risk Factor For Left Vnetricular
Hypertrophy in Human Essential Hypertension. Clinical Science. 117:6773.
Xu, Y., Arenas, I.A., Armstrong, S.J., Davidge, S.T., 2003. Estrogen modulation
of Left Ventricular Remodeling in the Aged Heart. Cardiovascular
Research. 57:388–394.
Yogiantoro, M. 2007. Hipertensi Esensial dalam Buku Ajar Ilmu Penyakit Dalam
Jilid I (ed. 4). Jakarta: Fakultas Kedokteran UI. h:599.
Yusuf, I. 2008. Hipertensi Sekunder dalam Medicinus Vol 21 Juli-September
No.3. Bagian Ilmu Penyakit Dalam FKUI/RSCM. Jakarta. h:72-5.
Yasunari, K., Maeda, K., Nakamura, T., et al. 2005., Left Ventricular
Hypertrophy and Angiotensin II Receptor Blocking Agents dalam Curr.
Med. Chem. – Cardiovascular&Hematological Agents. Departement of
General Medicine and Cardiology, Graduate School of Medicine. Osaka:
Osaka City University. 61-7.
Adrogue,H.J., Madias, N.E., 2007. Mechanisms of Disease Sodium and Potassium
in the Pathogenesis of Hypertension. The New England Journal of
Medicine. 356:19.
Almaguer., Desai, M.Y., Mannting, F., 2009. Detection of Left Ventricular
Hypertrophy
by
Tc-99
TetrofosminGated-SPECT.
Medicina
Universitaria. 11(42):29-35.
Anggraini, A.D., Waren, A., Situmorang E., et al., 2009. Faktor –Faktor yang
berhubungan dengan Kejadian Hipertensi pada Pasien yang Berobat di
Poliklinik Dewasa Puskesmas Bangkinang Periode Januari Sampai Juni
2008. Riau : FK UNRI. h:1-7.
Ballistrieri, T., Mussato, K., 2008. dalam Pathophysiology Concepts of Altered
Health States (8th ed.). Philadelphia: Lippincott Williams & Wilkins. pp:
512-21.
Bandiara, R., 2008. An Update Management Concept in Hypertension.
SubBagian Ginjal Hipertensi Bag. Ilmu Penyakit Dalam FK UNPAD/RS
Dr.Hasan Sadikin. Bandung.
Barrios, V., Escobar, C., Calderon, A., et al., 2009. Electrocardiography Left
Ventricular Hypertrophy Regression Induced by an Angiotensin Receptor
Blocker-Based Regimen in Hypertensive Patients with Diabetes: Data
From The SARA Study. Journal of Renin-Angiotesin-Aldosterone System.
10: 168.
Borah, P.K., Hazarika, N.C., Biswas, D., Kalita, H.C., Mahanta, J., 2010.
Population-Specific Left Ventricular Hypertrophy in Three Groups from
The Northeastern Region of India. The National Medical Journal of
Indian. 23(6) :336-9.
Brashers, V.L., McCance, K.L., 2010. Structure and Function of The
Cardiovascular and Lymphatic Systems dalam Pathophysiology The
Biologic Basis For Disease in Adult and Children (6th ed.). Philadelphia:
Elsevier. pp: 1149-52.
Brilla, C.G., 2000. Clinical Relevance of Left Ventricular Hypertrophy Regression
dalam Heart and Metabolisme.Division of Cardiology, Philipps
University, Marburg, Germany. p: 14-9.
Brown, D.M., Giles, W.H., Croft, J.B., 2000. Left Ventricular Hypertrophy As A
Predictor of Coronary Heart Disease Mortality and The Effect of
Hypertension. American Heart J Vol140 No.6. pp: 848-56.
Dahlan, S., 2004. Uji Hipotesis Komparatif Variabel Numerik 2 Kelompok dlam
Seri Statistik: Statistik untuk Kedokteran dan Kesehatan Uji Hipotesis
dengan Menggunakan SPSS Program 12 Jam. Jakarta: Arkans. h:77-8.
Departemen Kesehatan RI. 2007. Pedoman Pengendalian Penyakit Jantung dan
Pembuluh Darah. Jakarta. h:11.
Dominiczak, A.F.,Munroe, B.P., 2010. Genome-Wide Association Studies Will
Unlock the Genetic Basis of Hypertension. Hypertension The Journal of
American Heart Association. 56:1017-20.
Dorland, W. A. N, 2002. Dorlan’s Illustrated Medical Dictionary (29th ed.).
Hartanto, H et al. (Alih Bahasa). Jakarta: EGC.
Douglas, P.S., Kaplan, N.M., 2010. Definition and Pathogenesis of Left
Ventricular Hypertrophy in Hypertension. In G.L. Bakris; A.M. Sheridan;
G.M. Saperia (Eds) Up To Date 18.3, Up To Date, Waltham, MA.
Dubey, R.K., Oparil, S., Imthurn, B., Jackson, E.K., 2002. Sex Hormones and
Hypertension. Cardiovascular Research. 53:688-708.
Efendi, D. 2003. Korelasi Dispersi QT dengan Hipertrofi Ventrikel Kiri pada
Penderita Hipertensi. Bagian Ilmu Penyakit Dalam Fakultas Kedokteran
Universitas Sumatera Utara. Sumatera Utara. h:1-6.
Elliott, W.J., Bakris., Black., 2004. Systemic Arterial Hypertension dalam Hurst’s
The Heart (11th ed.). New York: McGraw Hill Companies. pp: 1534-38.
Federal Bureau of Prisons. 2004. Hypertension dalam Clinical Practice
Guidelines. pp:1. Diakses pada 28 November 2010 dari
http://www.pdfchaser.com/pdf/Federal-Bureau-of-Prisons-Clinical
Guidelines-for-Social-Work-....html.
Gray, H.H., Dawskins, K.D., Simpson, L.A., Morgan, J.M., 2002. Hipertensi
dalam Lecture Notes on Cardiology (4th ed.). Agus, A., Rachmawati,
A.D. (Alih Bahasa). Jakarta: Erlangga. h: 58.
Gregg, E.W., Gu, Q., Cheng, Y.J., et al., 2007. Mortality Trends in Men and
Women with Diabetes, 1971 to 2000. Annals of Internal Medicine.
147:149-55.
Guyton, A.C., Hall, J.E., 2006. dalam Textbook Of Medical Physiology (11th ed.).
Irawati. et al. (Alih Bahasa). Jakarta: EGC. h: 172.
Idham, I., Sanjaya, W., 2005. Angiotensin-II dan Remodelling Vaskuler dalam
Cermin Dunia Kedokteran No. 147. Departemen Kardiologi dan
Kedokteran Vaskuler Fakultas Kedokteran Universitas Indonesia/ Rumah
Sakit Jantung dan Pembuluh Darah Harapan Kita. h: 16-9.
Hampton, J.R., 2006. dalam Dasar-Dasar EKG (ed. 6). Jakarta: EGC. h:24.
Hinderliter, A.L., Colindres, R.E., 2004. Hypertension dalam international
Student Edition Netter’s Cardiology (1st ed.). USA: Icon Learning
System. pp: 377.
Izzo, J.L., Gradman, A.H., 2004. Mechanisms and Management of Hypertensive
Heart Disease: From Left Ventricular Hypertrophy to Heart Failure. The
Medical Clinics of North America. USA. 88:1257-71.
Julian, D.G., Cowan, J.C., McLenachan, J.M., 2005. Hypertension and Heart
Disease
dalam
Cardiology
(8thed.).
Philadelphia:
Elsevier
Sauders.pp:304-305.
Kaplan, N.M. 2001. Hypertension and Atherosclerotic Vascular Disease dalam
Heart Disease (6th ed.). Philadelphia: W.B. Saunders Company. pp:94157.
Khalil, R.A., 2005. Sex Hormones as Potential Modulators of Vascular Function
in Hypertension. Hypertension The Journal of American Heart
Association. 46:249-254.
Khalil, S.A., Zaimi, S., Tazi, M.A., et al.,2009. Prevalence and Predictors of
White-Coat Hypertension in A Large Database of Ambulatory Blood
Pressure Monitoring. La Revue de Santé de la Méditerranée orientale
Vol. 15. pp:401.
Kotchen, T.A. 2008. Hypertension Vascular Disease dalam Harrison’s Principles
of Internal Medicine (17th ed.). New York: McGraw Hill Companies. pp:
1549-52.
Lip, G.Y.H., Felmeden, D.C., Beevers, D.G., 2000. Hypertension Heart Disease A
Complex Syndrome or A Hypertensive Cardiomyopathy? European
Heart Journal. 21:1653-65.
Luchner, A., Brockel, U., Muscholl, M., et al., 2002. Gender-Specific Differences
of Cardiac Remodeling in Subjects with Left Ventricular Dysfunction: A
Population-Based Study. Cardiovascular Research. 53:720–27.
Morrison, I.,, Clark, E., Macfarlane, P.W., 2007. Evaluation of The
Electrocardiographic Criteria for Left Ventricular Hypertrophy. Anatol J
Cardiol. 7:159-63.
Murti, B., 2006. Desain dan ukuran sampel untuk penelitian kuantitatif dan
Kualitatif di Bidang Kesehatan. Yogyakarta: Gajah Mada University
Press. h:112.
Nadar, S., Lip, G.Y.H., 2010. Hypertension and Target Organ Damage: Focus on
Left Ventricular Hypertrophy. The Year in Hypertension. Atlas Medical
Publishing Ltd. 32-44.
National High Blood Pressure Education Program Coordinating Commitee, 2003.
The seventh report of the Joint National Committee on Prevention,
Detection, Evaluation, and Treatment of High Blood Pressure.
Hypertension The Journal of American Heart Association. 42:1206-52.
Notoadmodjo, S., 2002. Metodologi Penelitian Kesehatan. Rineka Cipta. Jakarta.
h:88.
Panggabean, M.M. 2007. Penyakit Jantung Hipertensi dalam Buku Ajar Ilmu
Penyakit Dalam Jilid III (ed.4). Jakarta: Fakultas Kedokteran UI. h: 1639.
Pepine, C.J., Nicolas, W.W., Pauly, D.F., 2006. Estrogen and Different Aspects
of Vascular Disease in Women and Men dalam Circulation Research of
American Heart Association. American Heart Association. Greenville
Avenue, Dallas. pp: 459-60.
Purwanto, B., 2010. Current Rational Management of Hypertension Based on Its
Pathophysiology dalam MakalahOne Day Symposium Update
Management of Hypertension and Its Complication. pp: 20.
Roseim E.A., Muiesan, M.L., 2005. Pathophysiology and Treatment of
Hypertensive Left Ventricular Hypertrophy. Hypertension&Left
Ventricular Hypertrophy. Dialogues in Cardiovascular Medicine. 10: 318.
Rosei, E.A., Muiesan, M.L., Salvetti, M., 2006. Evaluation of Subclinical Target
Organ Damage for Risk Assessment and Treatment in the Hypertensive
Patients: Left Ventricular Hypertrophy. Journal American Society of
Nephrology. 17:104-8.
Radin, M.J., Holycross, B.J., Sharkey, L.C., et al., 2001. Gender Modulates
Activation of Renin-Angiotensin and Endothelin Systems in Hypertension
and Heart Failure. J Appl Physiol. 92:935-940.
Reckelhoff, J.F., 2005. Sex Steroid, Cardiovascular Disease, and Hypertension:
Unanswered Question and Some Speculations. Hypertension The Journal
of American Heart Association. 45:170-74.
Saitoh, M., Nishimura, H., Tanaka, T., Kondoh, T., 2005. Gender Related
Differences in Target Organ Damage in Untreated Patients with
Essential Hypertension. Internal Medicine.45.1503: 377-83.
Samarel, A.M., Walsh, R.A., 2008. Molecular and Cellular Biology of the
Normal, Hypertrophied, and Failibg Heart dalam Hurst’s The Heart
(12th ed.). New York: McGraw Hill. pp: 123-25.
Sanjaya, W., Soerinata, S., 2004. Peranan Faktor-Faktor Hemodinamik dan Non
Hemodinamik Dalam Mekanisme Patogenik Hipertrofi Ventrikel Kiri
dalam Cermin Dunia Kedokteran No. 143. Departemen Kardiologi dan
Kedokteran Vaskuler Fakultas Kedokteran Universitas Indonesia/ Rumah
Sakit Pusat Jantung Nasional Harapan Kita. Jakarta. h:15.
Sastroasmoro, S., 2008. Dasar – Dasar Metodologi Penelitian Klinis. Jakarta:
Sagung Seto. h:293.
Schreiber, M.J., Vidt, J.D.G., 2005. Hallmarks of Essential and Secondary
Hypertension dalam The Cleveland Clinic Intensive Review of Internal
Medicine (4th ed.). Philadelphia: Lippincott Williams & Wilkins.pp: 60210.
Sherwood, L., 2001. Human Physiology : From Cells to System Cetakan I.
Jakarta: EGC. pp: 300.
Soerinata, S., Sanjaya, W., 2005. Peranan Penghambat Reseptor Angiotensin II
dalam Hipertrofi Ventrikel Kiri dalam Cermin Dunia Kedokteran No.
147. Departemen Kardiologi dan Kedokteran Vaskuler Fakultas
Kedokteran Universitas Indonesia/ Rumah Sakit Jantung dan Pembuluh
Darah Harapan Kita. h: 13-5.
Spencer, C.G.C., Lip, G.Y.H., 2000. Target Organ Damage in Hypertension:
Who is at Risk? University Departement of Medicine, City Hospital,
Birmingham, UK. p:9-13.
Sugiyono. 2006. Statistika untuk Penelitian. Bandung: Alfabeta.
Talwar, S., Siebenhofer, A., Williams, B., Ng, L., 2000. Influence of
Hypertension, Left Ventricular Systolic Dysfunction on Plasma N
terminal proBNP. Heart. 83:278-82.
Tessy, A. 2007. Hipertensi pada Penyakit Ginjal dalam Buku Ajar Ilmu Penyakit
Dalam Jilid I (ed. 4). Jakarta: Fakultas Kedokteran UI. h: 604.
Victor, R. 2003. Arterial Hypertension dalam Cecil Textbook of Medicine (22nd
ed.). Philadelphia: Saunders. pp:347.
Vikrant, S., Tiwari, S.C., 2001. Essential Hypertension Pathogenesis and
Pathophysiology dalam Indian Academy of Clinical Medicine Vol.2 JulySeptember No.3. pp:140-57.
Wasterhout,C.M., Lauer, M.S., James, S., et al., 2007. Electrocardiographic Left
Ventricular Hypertrophy in GUSTO IV ACS: An Important Risk Marker
of Mortality in Women. European Heart Journal. 28: 2064–69.
Wiss, A.J.W. 2005. dalam Pathophysiology An Essential Text For The Allied
Health Professions. Philadelphia: Elsevier. pp:342-44.
Xin, Y., Song, X., Xue, H., et al., 2009. A Common Variant of The eNOS
geneb(E298D) is an Independent Risk Factor For Left Vnetricular
Hypertrophy in Human Essential Hypertension. Clinical Science. 117:6773.
Xu, Y., Arenas, I.A., Armstrong, S.J., Davidge, S.T., 2003. Estrogen modulation
of Left Ventricular Remodeling in the Aged Heart. Cardiovascular
Research. 57:388–394.
Yogiantoro, M. 2007. Hipertensi Esensial dalam Buku Ajar Ilmu Penyakit Dalam
Jilid I (ed. 4). Jakarta: Fakultas Kedokteran UI. h:599.
Yusuf, I. 2008. Hipertensi Sekunder dalam Medicinus Vol 21 Juli-September
No.3. Bagian Ilmu Penyakit Dalam FKUI/RSCM. Jakarta. h:72-5.
Yasunari, K., Maeda, K., Nakamura, T., et al. 2005., Left Ventricular
Hypertrophy and Angiotensin II Receptor Blocking Agents dalam Curr.
Med. Chem. – Cardiovascular&Hematological Agents. Departement of
General Medicine and Cardiology, Graduate School of Medicine. Osaka:
Osaka City University. 61-7.